Xenon Pharmaceuticals
(NASDAQ:XENE)
$43.05
0.05[0.12%]
At close: Mar 28
$43.05
0[0.00%]
After Hours: 4:00PM EDT
Consensus Rating1
Buy
Highest Price Target1
$63.00
Lowest Price Target1
$46.00
Consensus Price Target1
$48.81

Xenon Pharmaceuticals Stock (NASDAQ:XENE), Analyst Ratings, Price Targets, Predictions

Xenon Pharmaceuticals Inc has a consensus price target of $48.81, established from looking at the 39 latest analyst ratings. The last 3 analyst ratings were released from RBC Capital, Wedbush, and Needham on March 1, 2024. With an average price target of $56 between RBC Capital, Wedbush, and Needham, there's an implied 30.08% upside for Xenon Pharmaceuticals Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
1
Nov 23
2
Dec 23
2
Jan
2
Mar
3
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Wedbush
Needham
Citigroup
B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Xenon Pharmaceuticals

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/01/2024XENEBuy Now
Xenon Pharmaceuticals
$43.0527.76%RBC Capital
Brian Abrahams
$56 → $55MaintainsOutperformGet Alert
03/01/2024XENEBuy Now
Xenon Pharmaceuticals
$43.0518.47%Wedbush
Laura Chico
$46 → $51MaintainsOutperformGet Alert
03/01/2024XENEBuy Now
Xenon Pharmaceuticals
$43.0544.02%Needham
Serge Belanger
$50 → $62MaintainsBuyGet Alert
01/04/2024XENEBuy Now
Xenon Pharmaceuticals
$43.0544.02%Citigroup
David Hoang
→ $62Initiates → BuyGet Alert
01/02/2024XENEBuy Now
Xenon Pharmaceuticals
$43.0530.08%B of A Securities
Jason Gerberry
$52 → $56MaintainsBuyGet Alert
12/18/2023XENEBuy Now
Xenon Pharmaceuticals
$43.0544.02%Stifel
Stephen Willey
$53 → $62MaintainsBuyGet Alert
12/08/2023XENEBuy Now
Xenon Pharmaceuticals
$43.0546.34%Baird
Brian Skorney
→ $63Initiates → OutperformGet Alert
11/28/2023XENEBuy Now
Xenon Pharmaceuticals
$43.0530.08%RBC Capital
Brian Abrahams
$51 → $56MaintainsOutperformGet Alert
11/09/2023XENEBuy Now
Xenon Pharmaceuticals
$43.056.85%Wedbush
Laura Chico
$47 → $46MaintainsOutperformGet Alert
10/24/2023XENEBuy Now
Xenon Pharmaceuticals
$43.05Cantor Fitzgerald
Josh Schimmer
Assumes → OverweightGet Alert
09/22/2023XENEBuy Now
Xenon Pharmaceuticals
$43.0518.47%RBC Capital
Brian Abrahams
→ $51ReiteratesOutperform → OutperformGet Alert
08/22/2023XENEBuy Now
Xenon Pharmaceuticals
$43.0534.73%Cantor Fitzgerald
Charles Duncan
→ $58ReiteratesOverweight → OverweightGet Alert
08/10/2023XENEBuy Now
Xenon Pharmaceuticals
$43.059.18%Wedbush
Laura Chico
→ $47ReiteratesOutperform → OutperformGet Alert
08/10/2023XENEBuy Now
Xenon Pharmaceuticals
$43.0516.14%Needham
Serge Belanger
→ $50ReiteratesBuy → BuyGet Alert
07/17/2023XENEBuy Now
Xenon Pharmaceuticals
$43.0518.47%RBC Capital
Brian Abrahams
→ $51ReiteratesOutperform → OutperformGet Alert
06/21/2023XENEBuy Now
Xenon Pharmaceuticals
$43.0534.73%Cantor Fitzgerald
Charles Duncan
→ $58ReiteratesOverweight → OverweightGet Alert
06/15/2023XENEBuy Now
Xenon Pharmaceuticals
$43.0513.82%Guggenheim
Yatin Suneja
→ $49ReiteratesBuy → BuyGet Alert
05/10/2023XENEBuy Now
Xenon Pharmaceuticals
$43.059.18%Wedbush
Laura Chico
$44 → $47MaintainsOutperformGet Alert
04/25/2023XENEBuy Now
Xenon Pharmaceuticals
$43.0534.73%Cantor Fitzgerald
Charles Duncan
→ $58Initiates → OverweightGet Alert

FAQ

Q

What is the target price for Xenon Pharmaceuticals (XENE)?

A

The latest price target for Xenon Pharmaceuticals (NASDAQ: XENE) was reported by RBC Capital on March 1, 2024. The analyst firm set a price target for $55.00 expecting XENE to rise to within 12 months (a possible 27.76% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Xenon Pharmaceuticals (XENE)?

A

The latest analyst rating for Xenon Pharmaceuticals (NASDAQ: XENE) was provided by RBC Capital, and Xenon Pharmaceuticals maintained their outperform rating.

Q

When was the last upgrade for Xenon Pharmaceuticals (XENE)?

A

There is no last upgrade for Xenon Pharmaceuticals.

Q

When was the last downgrade for Xenon Pharmaceuticals (XENE)?

A

There is no last downgrade for Xenon Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Xenon Pharmaceuticals (XENE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xenon Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xenon Pharmaceuticals was filed on March 1, 2024 so you should expect the next rating to be made available sometime around March 1, 2025.

Q

Is the Analyst Rating Xenon Pharmaceuticals (XENE) correct?

A

While ratings are subjective and will change, the latest Xenon Pharmaceuticals (XENE) rating was a maintained with a price target of $56.00 to $55.00. The current price Xenon Pharmaceuticals (XENE) is trading at is $43.05, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.